Endoscopic Ultrasound-Guided Choledochoduodenostomy: Evaluating Safety and Efficacy for Biliary Drainage in Common Bile Duct Obstruction

Background/Introduction: Endoscopic Retrograde Cholangiopancreatography (ERCP) is the gold standard for managing biliary drainage in patients with Common Bile Duct (CBD) obstruction, boasting a success rate exceeding 95%. However, its efficacy is limited in cases involving tumor invasion of the duodenum or major papilla, as well as post-surgical conditions. Objectives: This study evaluates the outcomes of Endoscopic Ultrasound (EUS)-guided choledochoduodenostomy as an alternative for patients with unsuccessful ERCP due to malignant mid and lower-end biliary obstruction at our center. Methods: A single-center prospective observational study was conducted from September 2018 to March 2020, compiling data from patients with confirmed malignancy and mid to lower-end CBD block undergoing choledochoduodenostomy. Exclusion criteria included pregnancy, heart, renal, and hepatic failure, and bleeding disorders. The study assessed technical success (successful stent placement) and clinical success (≥50% reduction in serum total bilirubin at day 14). Procedure and follow-up complications were also documented. Results and Discussion: EUS-guided choledochoduodenostomy was performed on 12 patients with varying causes of biliary obstruction: seven with pancreatic cancer, one with periampullary carcinoma and lower CBD strictures, two with gallbladder carcinoma and mid-CBD block due to metastatic lymph nodes, and two with ampullary carcinoma. The mean bilirubin was 21.8 mg/dL (±3.4 mg/dL). The study showed a 100% technical success rate and a 91.67% clinical success rate. Minor procedure-related complications were observed, including one case of local bleeding and one case of stent blockage. Additionally, two patients experienced stent migration during follow-up. The 12- month follow-up revealed a 65% survival rate, with four patients succumbing to their underlying malignancy or other causes. Conclusion: EUS-guided choledochoduodenostomy is a safe and effective alternative for biliary drainage in patients with mid and lower-end malignant CBD block after failed ERCP.

Authors

Institutions

Publication Details

Journal
The International Journal of Gastroenterology and Hepatology Diseases
Published
2025-03-06
DOI
https://doi.org/10.2174/0126662906337669250214050953
Primary Topic
Gallbladder and Bile Duct Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endoscopic Ultrasound-Guided Choledochoduodenostomy: Evaluating Safety and Efficacy for Biliary Drainage in Common Bile Duct Obstruction

Mukundkumar V. Patel, Lalitkumar B. Patel, Dhruvkumar M. Patel, Ram Parihar et al.
1 links
The International Journal of Gastroenterology and Hepatology Diseases
Gallbladder and Bile Duct Disorders
article

Endoscopic Ultrasound-Guided Choledochoduodenostomy: Evaluating Safety and Efficacy for Biliary Drainage in Common Bile Duct Obstruction

Mukundkumar V. Patel, Lalitkumar B. Patel, Dhruvkumar M. Patel, Ram Parihar, Sanjay Rajput, Maitri M. Patel, Dhara K. Patel
article en

Abstract

Background/Introduction: Endoscopic Retrograde Cholangiopancreatography (ERCP) is the gold standard for managing biliary drainage in patients with Common Bile Duct (CBD) obstruction, boasting a success rate exceeding 95%. However, its efficacy is limited in cases involving tumor invasion of the duodenum or major papilla, as well as post-surgical conditions. Objectives: This study evaluates the outcomes of Endoscopic Ultrasound (EUS)-guided choledochoduodenostomy as an alternative for patients with unsuccessful ERCP due to malignant mid and lower-end biliary obstruction at our center. Methods: A single-center prospective observational study was conducted from September 2018 to March 2020, compiling data from patients with confirmed malignancy and mid to lower-end CBD block undergoing choledochoduodenostomy. Exclusion criteria included pregnancy, heart, renal, and hepatic failure, and bleeding disorders. The study assessed technical success (successful stent placement) and clinical success (≥50% reduction in serum total bilirubin at day 14). Procedure and follow-up complications were also documented. Results and Discussion: EUS-guided choledochoduodenostomy was performed on 12 patients with varying causes of biliary obstruction: seven with pancreatic cancer, one with periampullary carcinoma and lower CBD strictures, two with gallbladder carcinoma and mid-CBD block due to metastatic lymph nodes, and two with ampullary carcinoma. The mean bilirubin was 21.8 mg/dL (±3.4 mg/dL). The study showed a 100% technical success rate and a 91.67% clinical success rate. Minor procedure-related complications were observed, including one case of local bleeding and one case of stent blockage. Additionally, two patients experienced stent migration during follow-up. The 12- month follow-up revealed a 65% survival rate, with four patients succumbing to their underlying malignancy or other causes. Conclusion: EUS-guided choledochoduodenostomy is a safe and effective alternative for biliary drainage in patients with mid and lower-end malignant CBD block after failed ERCP.

The International Journal of Gastroenterology and Hepatology DiseasesVol. 04
Gujarat University (IN), Gujarat Cancer & Research Institute (IN), Zydus Lifesciences Limited (India) (IN), Smt. N.H.L. Municipal Medical College (IN), Louisiana State University Health Sciences Center Shreveport (US)
Openalex Percentile: Top 94%
Gallbladder and Bile Duct Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.